Dynamic changes of pancreatic structure and function in rats treated chronically with nicotine.
Adult, male Sprague-Dawley rats weighing initially 185-225 g, were treated with 5, 15, or 50 mg nicotine or placebo 3-week-release pellets by sc implantation, for 1.5, 3, 6 and 12 weeks. These doses of nicotine correspond to infusion rates of 9.9, 29.8, and 99.2 micrograms/h, respectively. At the highest nicotine dose trypsin and chymotrypsin activities were markedly higher in pancreas from 12-week nicotine-treated rats compared with controls. This was associated with a fourfold increase in steady-state amylase mRNA levels in comparison to placebo controls. In addition, secretagogue-stimulated enzyme release from pancreatic acini isolated from rats treated with 50 mg nicotine pellets was significantly higher than controls at 1.5 and 3 weeks and declined below control levels after 12 weeks of treatment. In rats treated with 15-mg nicotine pellets, maximal secretagogue-stimulated enzyme release from isolated acini occurred at 1.5 weeks, declining thereafter to control levels. Electron microscopy of pancreas from rats treated with the 50 mg nicotine dose revealed intracytoplasmic vaculoes appearing after 3 weeks of treatment, and persisting throughout the remaining experimental period. It is concluded that 12-week nicotine treatment results in increased pancreatic enzyme biosynthesis and accumulation of digestive enzymes within the pancreas. This is associated with altered responsiveness to secretagogues and evidence of morphological damage.
Department of Medicine, Department of Veterans Affairs Medical Center, Martinez, California 94553.
P P
PP
Lau
M A
MA
Dubick
G S
GS
Yu
P R
PR
Morrill
M C
MC
Geokas
D000681:Amylases / Q000378:metabolism; D000818:Animals; D015152:Blotting, Northern; D001835:Body Weight / Q000187:drug effects; D002918:Chymotrypsin / Q000378:metabolism; D004247:DNA / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D008297:Male; D009538:Nicotine / Q000633:toxicity*; D009929:Organ Size / Q000187:drug effects; D010179:Pancreas / Q000033:anatomy & histology / Q000187:drug effects* / Q000378:metabolism; D011506:Proteins / Q000378:metabolism; D012313:RNA / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains; D012844:Sincalide / Q000378:metabolism; D014357:Trypsin / Q000378:metabolism; D014362:Trypsinogen / Q000378:metabolism; D014617:Vacuoles / Q000187:drug effects
D011506:Proteins; D012313:RNA; D009538:Nicotine; D014362:Trypsinogen; D004247:DNA; D000681:Amylases; D002918:Chymotrypsin; D014357:Trypsin; D012844:Sincalide